Park Square is pleased to announce the placement of Kurt Haggstrom as Chief Commercial Officer at Synchron, an endovascular brain-computer interface company.
| less than a minute read
Synchron Appoints Kurt Haggstrom as Chief Commercial Officer
Get in touch
Get in touch
“We are thrilled to have Kurt join the team. Kurt will bring world-class commercial leadership to ensure we have designed the product and clinical trials in readiness for launch of the first commercial implantable BCI into the U.S. market,” said Tom Oxley, CEO, Synchron. “Kurt joins us at a crucial moment in our development, on the heels of successful clinical results in our Australia trial, and commencement of our U.S. trial.”
Get in touch
Get in touch
Latest Insights
